Members of the Endocrine Society have elected five new Officers and Council members to lead the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology.
The new Officers and Council members are:
- President-Elect: Gary Hammer, MD, PhD
- Vice President (Physician-in-Practice): Whitney Goldner, MD
- Council (Basic Science Seat): Joy Wu, MD, PhD
- Council (At-Large Seat): Samantha Butts, MD, MSCE
- Council (At-Large Seat): Ghada El-Hajj Fuleihan, MD, MPH
The new Officers and Council members will begin serving their terms following ENDO 2019. The Society’s annual meeting will take place in New Orleans, La. from March 23-26, 2019.
Hammer will serve as president-elect in 2019-2020 and then as president in 2020-2021. He is director of the Endocrine Oncology Program at the University of Michigan in Ann Arbor, Mich. Hammer has been a Society member since 1999, and has since served on several committees and various journal editorial boards. These include the Governance Task Force, the Endocrine Reviews Editor-in-Chief Search Committee, the Strategic Plan Retreat, the Endocrine News Advisory Board, and the Committee on Governance Affairs. He’s also served as the chair of the Annual Meeting Steering Committee and of the Scientific and Educational Programs Core Committee. His awards and honors include the Endocrine Society’s 2013 Edwin B. Astwood Award Lecture for Outstanding Research in Endocrinology and the University of Michigan’s 2005 Jerome Conn Award for Outstanding Research.
Goldner will serve a three-year term as vice president, physician-in-practice (2019-2022). She is a professor of medicine of the Division of Diabetes, Endocrinology and Metabolism at the University of Nebraska Medical Center in Omaha, Neb. Goldner has been a Society member since 2002, and she currently serves as the chair of the Society’s Clinical Endocrinology Update Committee and as a member of the Endocrine Educators Forum. Goldner has won the University of Nebraska, Department of Internal Medicine Top Teacher Award 12 times since 2005.
Wu will serve a three-year term in the basic science-designated seat on Council (2019-2022). She is an assistant professor of medicine at the Stanford University School of Medicine in Stanford, Calif. She’s currently a member of the Society’s Publications Core Committee and previously served as a 2017 Strategic Plan Retreat member and a 2015 Leadership Development Task Force member. Her awards and honors include the Endocrine Society’s Endocrine Scholars Award and Merck Senior Fellow Award, the NIH Director’s New Innovator Award, and the John Haddad Young Investigator Award for Advances in Mineral Metabolism.
Butts will serve a three-year term as an at-large member of Council (2019-2022). She is an associate professor at the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pa. She’s currently a member of the Society’s Governance Task Force and serves as an Editorial Board member for The Journal of Clinical Endocrinology & Metabolism. She was previously a Member of the Advocacy and Public Outreach Core Committee from 2014 to 2016. Her awards and honors include the 2009 Penn Center for Excellence in Environmental Toxicology (CEET) New Investigator Award and the 2011 National Faculty Award from The American College of Obstetricians and Gynecologists and The Council on Resident Education in Obstetrics and Gynecology.
Fuleihan will serve a three-year term as an at-large member of Council (2019-2022). She is a professor of medicine at the American University of Beirut in Beirut, Lebanon. She currently serves as the Clinical Science Chair of the Society’s Annual Meeting Steering Committee and was previously a Strategic Planning Task Force member from 2015 to 2016. Her awards and honors include the Endocrine Society’s International Excellence in Endocrinology Award, the Harvard T.H. Chan School of Public Health Merit Award, and a lifelong appointment as a Lown Scholar for the Harvard T.H. Chan School of Public Health.
Loading ...